+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathy Pain Drug"

Global Neuropathy Pain Treatment Market 2024-2028 - Product Thumbnail Image

Global Neuropathy Pain Treatment Market 2024-2028

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Global Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 190 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Neuropathy Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathy Pain Drugs are used to treat the pain associated with peripheral neuropathy, a condition caused by damage to the peripheral nervous system. These drugs are typically prescribed to patients with diabetes, HIV, and chemotherapy-induced neuropathy. Commonly prescribed Neuropathy Pain Drugs include anticonvulsants, antidepressants, and opioids. The Neuropathy Pain Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, and Merck & Co. Other companies in the market include AbbVie, AstraZeneca, Eli Lilly, and Teva Pharmaceuticals. Show Less Read more